Entries by Rebecca Mercer

Congratulations to the 2021 CCRA Award Winners!

Recognizing Outstanding Contributions to the Canadian Cancer Research Community On November 8, 2022, the CCRA recognized five outstanding leaders in the Canadian cancer research community at their 2021 Canadian Cancer Research Conference. The 2021 Award Recipients are: Barry Stein, President & CEO Colorectal Cancer Canada is the recipient of theCCRA Award (more…)

Canadian Cancer Statistics 2021 Now Available!

Developed in collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada, with data provided by provincial and territorial cancer registries, this publication provides foundational information of the impact of cancer in Canada. For example, it shows a projected 229,200 cancer diagnoses and 84,600 cancer (more…)

5th Patient Group Pathway Model to Accessing Cancer Clinical Trials and Real-World Evidence Conference

The 2021, 5th Cancer Clinical Trials and RWE  Conference Registration is Open!  The Registration link is:   https://tinyurl.com/CTCONF2021 Over the course of the past several years, Colorectal Cancer Canada (CCC) has endeavoured and made significant progress in fostering patient and patient group partnerships among stakeholders who have been advocating for their engagement (more…)

Ontario Health – Person-Centred Virtual Cancer Care Clinical Guidance document

The Person-Centred Virtual Cancer Care Clinical Guidance document is now available. The COVID-19 pandemic has significantly increased the use of virtual care in many areas, such as cancer care. During the first 7 months of the pandemic, virtual cancer care visits (including telephone or video appointments) increased from ~1-2% to (more…)

New Publication: Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group

We are happy to announce that CanREValue’s latest publication, Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group, has been accepted for publication in Current Oncology. Download a copy of this paper. Abstract The Canadian (more…)

RFP – International Cancer Benchmarking Partnership COVID-19 Commissioned Research

Deadline to Submit Expression of Interest: October 22, 2021 Deadline for Full Proposal: November 1, 2021 Study Start Date: November 2021 Study Deadline: May 23, 2022 Budget: up to £40,000  (~$67,000 CAD) For full details see attached .pdf The ICBP is commissioning research that will develop an understanding how COVID-19 impacted cancer services and (more…)

University of Calgary – Postdoctoral Fellow Position in Real-World Evidence Analytics

Area: Real World Evidence Analytics Duration: one year with possibility of extension Start date: January 1, 2022 Salary: $50,000 plus benefits The Department of Oncology, Cumming School of Medicine at the University of Calgary is accepting applications for a Postdoctoral Scholar in Real-World Evidence Analytics. Click here to download full (more…)

IAEA soliciting applications from National Cancer Control Planning Experts

Closing Date:  October 18 2021 The International Atomic Energy Agency’s Programme of Action for Cancer Therapy (PACT), in collaboration with the World Health Organization (WHO), is soliciting applications from qualified National Cancer Control Planning Experts. More detailed information can be found through the link here. Main Purpose: In order to (more…)